Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie breast cancer drug falls short in Phase 2
AbbVie breast cancer drug falls short in Phase 2
AbbVie breast cancer drug falls short in Phase 2
Submitted by
admin
on December 7, 2016 - 7:45pm
Source:
BioPharma Dive
News Tags:
AbbVie
breast cancer
veliparib
PARP inhibitors
BRCA-mutant breast cancer
Headline:
AbbVie breast cancer drug falls short in Phase 2
Do Not Allow Advertisers to Use My Personal information
